Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210033655 210013676 1.7 null Disease modification (D) 2019-06-24 2019-06-29 Lenalidomide Cycle 26 onwards (PAS) Y N 210001193 CHLVPP
210033656 210022543 1.75 91.65 Palliative (P) 2019-08-10 2019-08-18 CVP N N 210004103 PEMBROLIZUMAB
210033657 210013688 1.82 0 Curative (C) null 2018-02-13 AML 19 TRIAL 01 N 210008796 CISPLATIN + VINORELBINE
210033658 210013691 1.68 60.6 Palliative (P) 2016-08-30 2017-11-02 Mitomycin Intravesical N N 210010386 ALL
210033659 210022554 null 64.1 Palliative (P) 2017-11-03 2017-11-03 Cytarabine intrathecal Y N 210011848 PIXANTRONE
210033660 210022555 1.7 83 Palliative (P) 2019-03-27 2019-03-27 LENALIDOMIDE + dexamethasone N N 210012655 CLL210 TRIAL
210033661 210013709 null 72 Palliative (P) 2018-08-15 2018-08-15 CAV N N 210021324 R-EPOCH
210033662 210013714 1.54 61.7 Curative (C) 2018-02-26 2018-02-26 PNET 4 HIT-SIOP Maintenance 02 N 210021743 ALL
210033663 210013718 1.46 94.9 Palliative (P) 2017-06-05 2017-07-31 CARBOPLATIN + PACLITAXEL N N 210021911 OFATUMUMAB
210033664 210013721 null null Palliative (P) null 2016-08-04 Lenalidomide 25mg (Cycle 1 to 25) Y N 210022095 PENTOSTATIN + RITUXIMAB
210033665 210013731 1.82 77.7 Palliative (P) 2017-09-05 2017-09-06 Fludarabine IV N N 210023716 CYCLOPHOSPHAMIDE + LENALIDOMIDE
210033666 210022581 1.76 99.7 Disease modification (D) 2015-10-21 2015-11-29 DOXORUBICIN N N 210024647 CYTARABINE INTRATHECAL
210033667 210013745 0 78 Curative (C) 2019-09-23 2019-09-23 Mini BEAM N Y 210024837 CYTARABINE HD + METHOTREXATE HD
210033668 210022585 null 117.5 Curative (C) 2017-11-08 2017-11-08 BR14 TRIAL 2 N 210025077 CISPLATIN + GEMCITABINE + RITUXIMAB
210033669 210013751 1.86 98 Curative (C) 2016-11-09 2016-11-09 PACLITAXEL Y N 210025389 UKALL 60+ TRIAL
210033670 210013759 1.56 null null 2017-01-08 2017-01-08 DOXORUBICIN null N 210025962 DA
210033671 210013761 1.85 null Curative (C) 2018-04-04 2018-08-23 Cytarabine intrathecal 02 N 210026674 BORTEZOMIB
210033672 210013770 0 60.4 Curative (C) 2014-09-21 2014-10-25 Vinorelbine IV N N 210027566 ABVD
210033673 210013774 1.88 null Curative (C) 2019-04-04 2019-04-04 ALEMTUZUMAB + BUSULFAN + FLUDARABINE Y N 210027899 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210033674 210013781 1.75 88 Curative (C) 2019-07-05 2019-07-05 CISPLATIN + VINORELBINE + RT N null 210028000 DAUNORUBICIN
210033675 210013782 1.67 90.95 null 2015-09-06 2015-09-06 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB null N 210028065 AML19 TRIAL
210033676 210013785 1.46 65.3 Palliative (P) 2018-03-19 2018-03-22 Carboplatin + Paclitaxel (weekly) Y N 210028634 CYTARABINE HD + METHOTREXATE HD
210033677 210013796 1.87 81.8 Curative (C) 2018-04-17 2018-04-21 Bevacizumab + LOMUSTINE 2 N 210029239 R CODOX M
210033678 210013800 1.72 63.3 Curative (C) 2019-03-16 2019-04-06 Packer Maintenance Regimen N null 210029407 CYTARABINE HD + METHOTREXATE HD
210033679 210013803 1.7 63 Palliative (P) 2016-09-14 2016-09-18 Ofatumumab Loading Y N 210029552 ALEMTUZUMAB + CYCLO + FLUDARABINE
210033680 210013807 1.67 76.6 Curative (C) 2015-11-02 2015-11-03 Capecitabine (21days) + Carboplatin N null 210029666 R CODOX M
210033681 210022624 1.68 44.9 Curative (C) 2019-02-05 2019-02-08 ABVD 2 N 210030225 DACTINOMYCIN + VINCRISTINE
210033682 210028195 1.82 76.8 Curative (C) 2018-07-19 2018-07-19 BR14 TRIAL N Y 210030276 CLL210 TRIAL
210033683 210028196 null 16.5 Curative (C) 2018-05-02 2018-09-15 PENTOSTATIN + RITUXIMAB N null 210030490 NHL 2003
210033684 210013818 1.72 89 Curative (C) 2018-06-03 2018-11-27 DACTINOMYCIN + CYCLO + VINCRISTINE 02 N 210030551 CARFILZOMIB
210033685 210013826 null null Curative (C) 2016-05-04 2016-05-04 Nilotinib N null 210030851 CVD
210033686 210013835 1.52 null Neo-adjuvant (N) 2017-01-18 2017-01-18 BR14 TRIAL 02 N 210031093 CARBO + ETOPOSIDE + VINCRISTINE
210033687 210013840 1.73 66.2 Palliative (P) 2017-07-30 2017-07-30 PIXANTRONE N N 210031205 TAMIGA TRIAL
210033688 210013844 1.85 18.1 Curative (C) 2019-01-23 2019-01-26 RUXOLITINIB N Y 210031222 CYCLO + FLUDARABINE + RITUXIMAB
210033689 210022642 1.7 112.8 Curative (C) 2018-04-21 2018-04-28 FCR IV - Cycle 2 onwards Y N 210031422 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210033690 210013846 1.5 82.3 null 2019-06-16 2019-09-14 PACLITAXEL N N 210031442 ALL
210033691 210013850 1.9 87.6 Curative (C) 2016-11-27 2016-12-25 Packer Maintenance Regimen Y N 210031639 ALL
210033692 210022653 0 68.8 Curative (C) 2018-02-23 2018-03-04 CYCLET N N 210032185 ALL MAINTENANCE
210033693 210028214 1.66 35.5 Curative (C) null 2018-02-27 Capecitabine (21days) + Carboplatin N N 210032710 DABRAFENIB + TRAMETINIB
210033694 210013877 null 10.8 Palliative (P) 2018-04-13 2018-04-15 CLL210 TRIAL N N 210032994 BEVACIZUMAB + IRINOTECAN
210033695 210028217 1.73 30.2 Palliative (P) 2019-01-01 2019-01-01 Cytarabine intrathecal 02 N 210033021 CYCLOPHOSPHAMIDE HIGH DOSE
210033696 210013880 null 8.8 Curative (C) 2017-10-26 2017-11-01 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE 02 N 210033199 VINORELBINE
210033697 210022665 1.85 0 Curative (C) 2017-10-07 2019-02-28 VEDex N N 210033602 DOCETAXEL
210033698 210013891 1.74 59.45 Disease modification (D) null 2019-06-22 CLARITY Trial 2 N 210033677 NHL 2003
210033699 210013895 1.63 84 Palliative (P) 2017-11-14 2017-12-05 CYCLET 1 N 210033710 CYTARABINE
210033700 210013899 null 13.3 Adjuvant (A) 2018-11-29 2019-01-09 LOMUSTINE + VINCRISTINE N N 210033837 IVAC
210033701 210013903 1.56 79.75 Not known (9) 2019-02-17 2019-03-10 Azacitidine 99 Y 210033864 BEAM
210033702 210022678 null 46.3 null 2020-04-07 2020-04-07 VINORELBINE null null 210034315 UKALL2003
210033703 210013915 1.65 6.25 Palliative (P) 2016-05-09 2016-05-25 ALL Int Guide B Int Maint Ph III N N 210034385 FLUDARABINE + MELPHALAN
210033704 210022683 1.82 null Curative (C) 2019-06-01 2019-06-30 Capecitabine + Oxaliplatin 21day 2 N 210034391 DOCETAXEL